Kynmobi and Paraesthesia - a phase IV clinical study of FDA data

Summary:

Paraesthesia is reported as a side effect among people who take Kynmobi (apomorphine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Rytary, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Paraesthesia when taking Kynmobi. It is created by eHealthMe based on reports of 2,384 people who have side effects when taking Kynmobi from the FDA, and is updated regularly.

What is Kynmobi?

Kynmobi has active ingredients of apomorphine hydrochloride. eHealthMe is studying from 2,384 Kynmobi users. Check the latest studies of Kynmobi.

What is Paraesthesia?

Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect) is found to be associated with 2,689 drugs and 3,120 conditions by eHealthMe. Check the latest studies of Paraesthesia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

2,384 people reported to have side effects when taking Kynmobi.
Among them, 26 people (1.09%) have Paraesthesia.

Could Kynmobi cause Paraesthesia?

Among these 26 people:

How long have people been on Kynmobi when they have Paraesthesia? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Paraesthesia when taking Kynmobi? *

  • female: 60 %
  • male: 40 %

What is the age of people who have Paraesthesia when taking Kynmobi? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 24 %
  • 60+: 76 %

What are other drugs people take besides Kynmobi? *

  1. Rytary: 2 people, 7.69%
  2. Tigan: 1 person, 3.85%
  3. Sinemet: 1 person, 3.85%
  4. Risedronate Sodium: 1 person, 3.85%
  5. Promethazine: 1 person, 3.85%
  6. Prednisone: 1 person, 3.85%
  7. Ondansetron: 1 person, 3.85%
  8. Nourianz: 1 person, 3.85%
  9. Neupro: 1 person, 3.85%
  10. Losartan Potassium: 1 person, 3.85%

What are other side effects people have besides Paraesthesia? *

  1. Dizziness: 7 people, 26.92%
  2. Drowsiness: 7 people, 26.92%
  3. Feeling Abnormal: 7 people, 26.92%
  4. Hypoaesthesia (reduced sense of touch or sensation): 7 people, 26.92%
  5. Nausea (feeling of having an urge to vomit): 6 people, 23.08%
  6. Hypotension (abnormally low blood pressure): 4 people, 15.38%
  7. Burning Sensation: 3 people, 11.54%
  8. Fatigue (feeling of tiredness): 3 people, 11.54%
  9. Chest Pain: 2 people, 7.69%
  10. High Blood Pressure: 2 people, 7.69%

What are the existing conditions these people have? *

  1. Parkinson's Disease: 10 people, 38.46%
  2. On And Off Phenomenon: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Kynmobi and have Paraesthesia?

- Check whether Paraesthesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kynmobi:

Paraesthesia treatments and more:

How severe was Paraesthesia and when was it recovered:

Expand to all the drugs that have ingredients of apomorphine hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kynmobi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paraesthesia:

Browse all the conditions that are associated with Paraesthesia:


How the study uses the data?

The study uses data from the FDA. It is based on apomorphine hydrochloride (the active ingredients of Kynmobi) and Kynmobi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: